Loss of astrocytic glutamate transporters in Wernicke encephalopathy
Article first published online: 29 JUN 2009
Copyright © 2009 Wiley-Liss, Inc.
Volume 58, Issue 2, pages 148–156, 15 January 2010
How to Cite
Hazell, A. S., Sheedy, D., Oanea, R., Aghourian, M., Sun, S., Jung, J. Y., Wang, D. and Wang, C. (2010), Loss of astrocytic glutamate transporters in Wernicke encephalopathy. Glia, 58: 148–156. doi: 10.1002/glia.20908
- Issue published online: 12 NOV 2009
- Article first published online: 29 JUN 2009
- Manuscript Accepted: 28 MAY 2009
- Manuscript Received: 11 OCT 2008
- Canadian Institutes of Health Research. Grant Number: MOP-84497
- thiamine deficiency;
- vitamin B1;
- oxidative stress
Wernicke encephalopathy (WE), a neurological disorder caused by thiamine deficiency (TD), is characterized by structural damage in brain regions that include the thalamus and cerebral cortex. The basis for these lesions is unclear, but may involve a disturbance of glutamatergic neurotransmission. We have therefore investigated levels of the astrocytic glutamate transporters EAAT1 and EAAT2 in order to evaluate their role in the pathophysiology of this disorder. Histological assessment of the frontal cortex revealed a significant loss of neurons in neuropathologically confirmed cases of WE compared with age-matched controls, concomitant with decreases in α-internexin and synaptophysin protein content of 67 and 52% by immunoblotting. EAAT2 levels were diminished by 71% in WE, with levels of EAAT1 also reduced by 62%. Loss of both transporter sites was confirmed by immunohistochemical methods. Development of TD in rats caused a profound loss of EAAT1 and EAAT2 in the thalamus accompanied by decreases in other astrocyte-specific proteins. Treatment of TD rats with N-acetylcysteine prevented the downregulation of EAAT2 in the medial thalamus, and ameliorated the loss of several other astrocyte proteins, concomitant with increased neuronal survival. Our results suggest that (1) loss of EAAT1 and EAAT2 glutamate transporters is associated with structural damage to the frontal cortex in patients with WE, (2) oxidative stress plays an important role in this process, and (3) TD has a profound effect on the functional integrity of astrocytes. Based on these findings, we recommend that early treatment using a combination of thiamine AND antioxidant approaches should be an important consideration in cases of WE. © 2009 Wiley-Liss, Inc.